NUCLEOLIN and intrahepatic cholangiocarcinoma: In intrahepatic cholangiocarcinoma, lactylation of nucleolin at K477 alters the structure of the nucleolin and regulates its binding to the mRNA of the MAP kinase-activated death domain protein (MADD), thereby preventing premature termination of translation (94).